Psychometric tests for diagnosing minimal hepatic encephalopathy

Karin Weissenborn1

  • 1Department of Neurology, Hannover Medical School, 30623 Hannover, Germany. weissenborn.karin@mh-hannover.de

Metabolic Brain Disease
|September 21, 2012
PubMed

Insights

Diagnosing minimal hepatic encephalopathy (mHE) lacks standardized tools, impacting patient care. Further research is needed to determine the most effective diagnostic methods for mHE.

Area of Science:

  • Hepatology
  • Neuropsychology
  • Clinical Diagnostics

Background:

  • Minimal hepatic encephalopathy (mHE) significantly affects daily living, necessitating diagnosis and treatment.
  • Current diagnostic approaches for mHE lack consensus on optimal methods.
  • Established psychometric tests include the Inhibitory Control Test, Psychometric Hepatic Encephalopathy Score (PHES), and Critical Flicker Frequency.

Purpose of the Study:

  • To review current diagnostic tools for minimal hepatic encephalopathy (mHE).
  • To highlight the lack of consensus on the most appropriate diagnostic methods for mHE.
  • To identify critical data gaps hindering optimal mHE diagnosis.

Main Methods:

  • Review of frequently used psychometric and neurophysiological tests for mHE diagnosis.
  • Consideration of recommendations from the International Society for Hepatic Encephalopathy and Nitrogen Metabolism.
  • Identification of limitations in current diagnostic data.

Main Results:

  • Multiple diagnostic tools are used for mHE, including PHES, Inhibitory Control Test, and Critical Flicker Frequency.
  • PHES and Repeatable Battery for the Assessment of Neuropsychological Status are recommended by a leading society.
  • The Continuous Reaction Time Test is regaining interest, but data is limited.
  • Crucial information on test result variability (age, sex, education, comorbidities) is missing for most methods.

Conclusions:

  • There is no consensus on the optimal diagnostic tools for minimal hepatic encephalopathy (mHE).
  • Significant data gaps exist regarding factors influencing test performance and reliability.
  • Future research must address these deficiencies to improve mHE diagnosis and patient management.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...